课题基金 / 基金详情

Assessment of Cardiotoxicity by Cardiac MRI in Early Stage Breast Cancer Patients Receiving Adjuvant Trastuzumab: A Prospective Observational Pilot Study

Assessment of Cardiotoxicity by Cardiac MRI in Early Stage Breast Cancer Patients Receiving Adjuvant Trastuzumab: A Prospective Observational Pilot Study
通过心脏 MRI 评估接受曲妥珠单抗辅助治疗的早期乳腺癌患者的心脏毒性：一项前瞻性观察性试点研究
批准号：
182372
负责人：
Brezden-Masley Christine
金额：
$2.73万
依托单位：
Unity Health Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-03-01 至 2012-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=182372&lang=en
关键词：
Cardiac Mri Cardiotoxicity Early Stage Breast Cancer Her-2 Overexpression Trastuzumab

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
About 25-30% of breast cancer patients have a more aggressive type of breast cancer which produces a protein called HER2. New therapy blocking this protein with an antibody (trastuzumab) has shown an approximate 50% reduction in the risk of this aggressiv
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金